3 results match your criteria: "The Netherlands Lymphoma and Myeloma Center Amsterdam - LYMMCARE[Affiliation]"
Chronic lymphocytic leukemia development is accelerated in mice with deficiency of the pro-apoptotic regulator NOXA.
Haematologica
September 2016
Department of Experimental Immunology, Academic Medical Center, The Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), The Netherlands
Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia.
Haematologica
March 2016
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands Lymphoma and Myeloma Center Amsterdam - LYMMCARE, The Netherlands
Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy.
Blood
April 2015
Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.